SynBioBeta Speaker

Amy Locks

Anzen Industries

CEO

Amy is the co-founder and CEO of Anzen Industries, a cell-free manufacturing company developing modular enzyme reactors to produce high-value chemicals. Anzen vertically integrates enzyme design, stabilisation and reactor engineering to enable more resilient and capital-efficient chemical manufacturing.Amy has a PhD in enzyme stabilisation from University College London, where she focused on rapid methods for enzyme durability and reusability. Anzen has raised $2.2M in pre-seed funding and is relocating to California to scale its technology and team.

Sessions Featuring

Amy

This Year

Breakout Session

•

3:30 PM

-

4:15 PM

Planetary Health

Biology Without Cells: The Rise of Cell-Free Biomanufacturing

Cell-free systems are redefining what’s possible in bioproduction. By bypassing the complexity of living cells, innovators can run enzyme cascades, prototype metabolic pathways, and produce high-value molecules with unmatched speed, precision, and purity. This new class of systems—from freeze-dried reactions to continuous cell-free reactors—enables rapid iteration, on-demand production, and scalable biochemistry without the need for fermentation tanks or long development cycles.

Featuring

Amy Locks

Anzen Industries

CEO

Enzyme-stabilization expert building cell-free modular “enzyme reactors.”

Jonathan Weinstein

Scala Biodesign

Prin. Scientist, Protein Design Alg. & AI

Christopher Pirie

Decycle Bio

CEO

De-novo, cell-free enzyme cascades converting waste into chemicals

Neeka Mashouf

Rubi Laboratories

CEO and Co-founder

Cynthia Collins

Ginkgo Bioworks

GM, Ginkgo Reagents

Kavya Sharman

Phase Capital

Managing Partner

Breakout Session

•

3:30 PM

-

4:15 PM

Planetary Health

Biology Without Cells: The Rise of Cell-Free Biomanufacturing

Cell-free systems are redefining what’s possible in bioproduction. By bypassing the complexity of living cells, innovators can run enzyme cascades, prototype metabolic pathways, and produce high-value molecules with unmatched speed, precision, and purity. This new class of systems—from freeze-dried reactions to continuous cell-free reactors—enables rapid iteration, on-demand production, and scalable biochemistry without the need for fermentation tanks or long development cycles.

Featuring

Amy Locks

Anzen Industries

CEO

Enzyme-stabilization expert building cell-free modular “enzyme reactors.”

Jonathan Weinstein

Scala Biodesign

Prin. Scientist, Protein Design Alg. & AI

Christopher Pirie

Decycle Bio

CEO

De-novo, cell-free enzyme cascades converting waste into chemicals

Neeka Mashouf

Rubi Laboratories

CEO and Co-founder

Cynthia Collins

Ginkgo Bioworks

GM, Ginkgo Reagents

Kavya Sharman

Phase Capital

Managing Partner

Previous Speakers Include